Myasthenia gravis associated with nivolumab therapy in patient with lung adenocarcinoma

Conclusions It is important for neurologists and oncologists to consider nivolumab as a possible aetiology of MG and to discontinue it before considering aggressive treatment for MG.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Tags: Abstracts Source Type: research